WallStreetZenWallStreetZen

NASDAQ: SOPH
Sophia Genetics Sa Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SOPH past revenue growth

How has SOPH's revenue growth performed historically?
Company
31.14%
Industry
11.97%
Market
16.96%
SOPH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SOPH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SOPH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SOPH earnings and revenue history

Current Revenue
$62.4M
Current Earnings
-$79.0M
Current Profit Margin
-126.6%

SOPH Return on Equity

Current Company
-47.4%
Current Industry
-0.2%
Current Market
188%
SOPH's Return on Equity (-47.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SOPH announces earnings.

SOPH Return on Assets

Current Company
-36.4%
Current Industry
0.8%
SOPH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SOPH Return on Capital Employed

Current Company
-48.35%
Current Industry
2.2%
SOPH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SOPH vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SOPH$62.37M-$74.12M-$78.98M+25.23%N/A
SPOK$139.03M$26.82M$15.67M-3.88%-28.83%
WGS$202.57M-$144.07M-$175.77M+8.72%N/A
HCAT$295.94M-$81.68M-$118.15M+21.33%N/A
MPLN$961.52M$651.93M-$91.70M-1.57%N/A
View Top Health Information Service Stocks

SOPH earnings dates

Next earnings date
May 7, 2024

Sophia Genetics Sa Earnings & Revenue FAQ

What were SOPH's earnings last quarter?

On Invalid Date, Sophia Genetics Sa (NASDAQ: SOPH) reported Q4 2023 earnings per share (EPS) of -$0.37, up 76.19% year over year. Total Sophia Genetics Sa earnings for the quarter were -$24.06 million. In the same quarter last year, Sophia Genetics Sa's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Sophia Genetics Sa stock.

What was SOPH's earnings growth in the past year?

As of Q2 2024, Sophia Genetics Sa's earnings has grown year over year. Sophia Genetics Sa's earnings in the past year totalled -$78.98 million.

What is SOPH's earnings date?

Sophia Genetics Sa's earnings date is Invalid Date. Add SOPH to your watchlist to be reminded of SOPH's next earnings announcement.

What was SOPH's revenue last quarter?

On Invalid Date, Sophia Genetics Sa (NASDAQ: SOPH) reported Q4 2023 revenue of $17.05 million up 27.38% year over year. In the same quarter last year, Sophia Genetics Sa's revenue was $13.38 million.

What was SOPH's revenue growth in the past year?

As of Q2 2024, Sophia Genetics Sa's revenue has grown 31.14% year over year. This is 19.17 percentage points higher than the US Health Information Services industry revenue growth rate of 11.97%. Sophia Genetics Sa's revenue in the past year totalled $62.37 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.